Download presentation
Presentation is loading. Please wait.
Published byRoxanne Jackson Modified over 7 years ago
3
Peripheral Arterial Disease Admissions
4
CLI AND PAD ADMISSIONS
5
Critical Limb Ischemia Outcomes
6
CLI/PAD predominance in Medicare and Medicaid Population
9
TREATMENT OPTIONS FOR PAD/CLI
SURGICAL REVASCULARIZATION CATHETER-BASED REVASCULARIZATION BIOELECTRIC STIMULATION STEM CELLS AMNIOTIC FLUID AND MEMBRANE GENE PLASMIDS
10
Bioelectric stimulation to Enhance Angiogenesis
I. Isolated skeletal muscle cells Stimulated using the precise signal for VEGF Confirmed increase VEGF mRNA in medium Resulted in enhanced Endothelial cell activatioin II. Animal Model of hind limb ischemia* Bioelectric stimulation too low to cause muscle contraction or discomfort Induced demonstrable increase in blood flow and VEGF expression in the muscle. Simple and effective strategy to enhance expression of targeted proteins in the target tissue *Kanno et al Circulation 1999
11
VEGF mRNA Expression increased 480 % in Skeletal Muscle
Increase in Capillary Density and VEGF Expression with Bioelectric Stimulation 230 % Increase P< 0.01 VEGF mRNA Expression increased 480 % in Skeletal Muscle Kanno S. Circ : Kanno S Circ 1999
12
BIOELETRIC STIMULATION FOR NON-HEALING WOUNDS DUE TO CLI
Czech Republic 41 Patients with diabetes and non-healing leg or foot ulcers of various etiologies; arterial or venous, or pressure; all had std wound care Bioelectric stimulation for minutes, 3 x’s/week for 8 weeks using 1.5 uA with cutaneous patch electrodes-induced no reported discomfort Over 90% Reduction in Wound Size by 8 weeks of this treatment. Wirsing et al internatl Wound J 2013
13
Patented Bioelectric Signals for Specific Target Proteins*
SDF Stem Cell Differentiating Signal VEGF Tropoelastin PDGF Activin A&B IGF Follistatin HGF eNOS EGF HIF-1 alpha Confirmed Expression in multiple tissues ONLY STRATEGY THAT STIMULATES HOMING/DIFFERENTIATION/PROLIFERATION
14
BIOELECTRIC STIMULATION FOR NON-HEALING ULCER
16
Bioelectric Stimulation for Non-Healing Wounds
International Wound J 2014
17
BIOELETRIC STIMULATION FOR NON-HEALING DIABETIC FOOT ULCERS
30 Patients with wound ulcers unresponsive to all conventional therapies Randomized, single blind, placebo control trial Bioelectric stimulation: On or Off 1 hr sessions, 3 x’s/week, for 4 weeks (12 total) 60 % Reduction in Wound Area, vs 20% Control Wound fluid after 1 treatment showed significant increase in HIF-1 alpha levels p=0.01 vs Control Also significant increase VEGF with wound healing Asadi et al Diabetes Res 2017
18
Abadi Diabetes Res 2017
19
Amniotic Fluid and Membrane
Fluid that bathes the fetus Readily available at C-Section deliveries Microarray analysis: 240 proteins-pro-regenerative and pro-angiogenic Membrane (chorion:amnion) lines uterine cavity Membrane Can be lipholized and shipped that can be used to cover the ulcer/wound, various sizes Now being used for burns and other wounds
20
AMNIOTIC MEMBRANE FOR WOUND HEALING
RANDOMIZED TRIAL OF 25 PATIENTS WITH NON-HEALING LEG ULCERS Goal: Could Am Membrane promote wound healing and reconstruction vs scarring and fibrosis GP 1: STANDARD CARE/DAILIY DRESSING CHANGE GP 2: TOPICAL COVERING OF ULCER WITH AMNIOITIC MEMBRANE + DAILY DRESSING CHANGE Follow Up at Day 7, 14, 21, 30, 45, and 60 Assessed rate and amount of wound healing, ulcer depth, and self-assessed pain El Hanidy et al Int J Womens’s Health 2016
21
AMNIOTIC MEMBRANE FOR WOUND HEALING
RESULTS GP 1: NO IMPROVEMENT IN WOUND HEALING ONLY 18% SHOWED ANY GRANULATION TISSUE NO IMPROVEMENT IN PAIN GP 2: ALL 14 PATIENTS HAD TOTAL WOUND HEALING WITHIN AVG 33 DAYS OF TREATMENT 13/14 HAD HEALTHY GRANULATION TISSUE 79% HAD SIGNIFICANT REDUCTION IN PAIN El Hanidy et al Int J Womens’s Health 2016
22
AMNIOTIC MEMBRANE FOR WOUND HEALING
RESULTS GP 1: GP 2 TREATMENT Control Am Membrane Wound Healing / /14 Granulation Tiss / /14 Pain Reduction / /14 El Hanidy et al Int J Womens’s Health 2016
23
Amniotic Fluid Membrane for Non-Healing Wounds
24
BIOELECTRIC STIMULATION FOR NON-HEALING ULCER
25
ADIPOSE DERIVED REGEN CELLS FOR CHRONIC LIMB ISCHEMIA
16 patients with CLI facing amputation ADRCs injected Intramuscularly along calf No complications of cell delivery RESULTS: 12/16 were spared amputation Very impressive wound healing Significant increase in blood flow by Angiogram Vaclav Prochazka Chech Repbulic
26
ADRCs for CLI
27
ADRCs for CLI PRE ADRCs POST ADRCs
28
CRITICAL LIMB ISCHEMIA NON-HEALING ULCER
29
CRITICAL LIMB ISCHEMIA NON-HEALING ULCER
30
CRITICAL LIMB ISCHEMIA NON-HEALING ULCER
31
CRITICAL LIMB ISCHEMIA NON-HEALING ULCER
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.